FDA OKs Drug for Cancer Patients With Weakened Bones

The FDA has approved the osteoporosis drug Prolia as a treatment for some breast and prostate cancer patients whose bones have been weakened by certain hormone therapies for cancer.

Go here to read the rest:

FDA OKs Drug for Cancer Patients With Weakened Bones

Posted by on September 20, 2011. Filed under Health, News. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.